Biblio Discovery — Demo Discovery Service

40 results for "Higginbottom, Adrian"

Showing 1–20 · 5.67 seconds · RSS

  1. Journal Article Full text

    An in vitro screening cascade to identify neuroprotective antioxidants in ALS

    Barber, Siân C.; Higginbottom, Adrian; Mead, Richard J. et al.

    Free Radic Biol Med · 2009 · English · PubMed Central

    Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease, characterized by progressive dysfunction and death of motor neurons. Although evidence for oxidative stress in ALS pathogenesis is well described, antioxidants have generally shown poor efficacy in animal models and…

  2. Journal Article Full text

    Distinct Regions of the Large Extracellular Domain of Tetraspanin CD9 Are Involved in the Control of Human Multinucleated Giant Cell Formation

    Hulme, Rachel S.; Higginbottom, Adrian; Palmer, John et al.

    PLoS One · 2014 · English · PubMed Central

    Multinucleated giant cells, formed by the fusion of monocytes/macrophages, are features of chronic granulomatous inflammation associated with infections or the persistent presence of foreign material. The tetraspanins CD9 and CD81 regulate multinucleated giant cell formation: soluble recombinant…

  3. Journal Article Full text

    CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection

    Zhang, Jie; Randall, Glenn; Higginbottom, Adrian et al.

    J Virol · 2004 · English · PubMed Central

    CD81 has been described as a putative receptor for hepatitis C virus (HCV); however, its role in HCV cell entry has not been characterized due to the lack of an efficient cell culture system. We have examined the role of CD81 in HCV glycoprotein-dependent entry by using a recently developed…

  4. Journal Article Full text

    Viral Delivery of Antioxidant Genes as a Therapeutic Strategy in Experimental Models of Amyotrophic Lateral Sclerosis

    Nanou, Aikaterini; Higginbottom, Adrian; Valori, Chiara F et al.

    Mol Ther · 2013 · English · PubMed Central

    Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder with no effective treatment to date. Despite its multi-factorial aetiology, oxidative stress is hypothesized to be one of the key pathogenic mechanisms. It is thus proposed that manipulation of the expression of…

  5. Journal Article Full text

    Dysregulation of astrocyte–motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis

    Ferraiuolo, Laura; Higginbottom, Adrian; Heath, Paul R. et al.

    Brain · 2011 · English · PubMed Central

    Amyotrophic lateral sclerosis is a neurodegenerative disease in which death of motoneurons leads to progressive failure of the neuromuscular system resulting in death frequently within 2–3 years of symptom onset. Focal onset and propagation of the disease symptoms to contiguous motoneuron groups is…

  6. Journal Article Full text

    A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening

    Da Costa, Marc M. J.; Allen, Claire E.; Higginbottom, Adrian et al.

    Dis Model Mech · 2013 · English · PubMed Central

    Mutations in the superoxide dismutase gene (SOD1) are one cause of familial amyotrophic lateral sclerosis [ALS; also known as motor neuron disease (MND)] in humans. ALS is a relentlessly progressive neurodegenerative disease and, to date, there are no neuroprotective therapies with significant…

  7. Journal Article Full text

    Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response

    Wright, Andrew J.; Higginbottom, Adrian; Philippe, Didier et al.

    Mol Immunol · 2007 · English · PubMed Central

    The chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS) is reported to bind to the receptors for C5a and formylated peptides and has been proposed as a promising lead for the development of new anti-inflammatory compounds. Here we have examined the receptor specificity and mode of action…

  8. Journal Article Full text

    Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation

    Buchman, Vladimir L; Cooper-Knock, Johnathan; Connor-Robson, Natalie et al.

    Mol Neurodegener · 2013 · English · PubMed Central

    BACKGROUND: Sizing of GGGGCC hexanucleotide repeat expansions within the C9ORF72 locus, which account for approximately 10% of all amyotrophic lateral sclerosis (ALS) cases, is urgently required to answer fundamental questions about mechanisms of pathogenesis in this important genetic variant…

  9. Journal Article Full text

    Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features

    Shaw, Matthew P.; Higginbottom, Adrian; McGown, Alexander et al.

    Acta Neuropathol Commun · 2018 · English · PubMed Central

    A hexanucleotide repeat expansion (HRE) within the chromosome 9 open reading frame 72 (C9orf72) gene is the most prevalent cause of amyotrophic lateral sclerosis/fronto-temporal dementia (ALS/FTD). Current evidence suggests HREs induce neurodegeneration through accumulation of RNA foci and/or…

  10. Journal Article Full text

    Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81

    Flint, Mike; Maidens, Catherine; Loomis-Price, Larry D. et al.

    J Virol · 1999 · English · PubMed Central

    A truncated soluble form of the hepatitis C virus E2 glycoprotein, E2(661), binds specifically to the surface of cells expressing human CD81 (hCD81) but not other members of the tetraspanin family (CD9, CD63, and CD151). No differences were noted between the level of E2(661) binding to hCD81…

  11. Journal Article Full text

    THE ROLE OF THE N-TERMINAL DOMAIN OF THE COMPLEMENT FRAGMENT RECEPTOR, C5L2, IN LIGAND BINDING

    Scola, Anne-Marie; Higginbottom, Adrian; Partridge, Lynda J et al.

    J Biol Chem · 2006 · English · PubMed Central

    C5L2 is a new cellular receptor found to interact with the human anaphylatoxins complement factor C5a and its C-terminal cleavage product C5a des Arg. The classical human C5a receptor (C5aR) preferentially binds C5a, with a 10-100-fold lower affinity for C5a des Arg. In contrast, C5L2 binds both…

  12. Journal Article Full text

    C9ORF72 transcription in a frontotemporal dementia case with two expanded alleles

    Cooper-Knock, Johnathan; Higginbottom, Adrian; Connor-Robson, Natalie et al.

    Neurology · 2013 · English · PubMed Central

    Discovery of intronic hexanucleotide repeat expansions of the C9ORF72 gene in a significant proportion of patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)(1,2) was an important step for research into these disorders. The C9ORF72 genetic variant is more common than…

  13. Journal Article Full text

    Recombinant Extracellular Domains of Tetraspanin Proteins Are Potent Inhibitors of the Infection of Macrophages by Human Immunodeficiency Virus Type 1

    Ho, Siu-Hong; Martin, Francine; Higginbottom, Adrian et al.

    J Virol · 2006 · English · PubMed Central

    Human immunodeficiency virus type 1 (HIV-1) infection of human macrophages can be inhibited by antibodies which bind to the tetraspanin protein CD63, but not by antibodies that bind to other members of the tetraspanin family. This inhibitory response was limited to CCR5 (R5)-tropic virus and was…

  14. Journal Article Full text

    Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells

    Parthasarathy, Varadarajan; Martin, Francine; Higginbottom, Adrian et al.

    Immunology · 2009 · English · PubMed Central

    Members of the tetraspanin superfamily of proteins are implicated in a variety of complex cell processes including cell fusion. However, the contribution of individual tetraspanins to these processes has proved difficult to define. Here we report the use of recombinant extracellular regions of…

  15. Journal Article Full text

    A neuronal DNA damage response is detected at the earliest stages of Alzheimer's neuropathology and correlates with cognitive impairment in the Medical Research Council's Cognitive Function and Ageing Study ageing brain cohort

    Simpson, Julie E.; Ince, Paul G.; Matthews, Fiona E. et al.

    Neuropathol Appl Neurobiol · 2015 · English · PubMed Central

    AIMS: Population‐based studies have shown that approximately 20% of the ageing population (aged 65 years and over) with dementia have little or no classical Alzheimer‐type neuropathology. Cumulative DNA damage and a reduced capacity of DNA repair may result in neuronal dysfunction and contribute to…

  16. Journal Article Full text

    Relationships of brain cholesterol and cholesterol biosynthetic enzymes to Alzheimer’s pathology and dementia in the CFAS population-derived neuropathology cohort

    Mistry, Hemant; Richardson, Connor D.; Higginbottom, Adrian et al.

    Neurosci Res · 2024 · English · PubMed Central

    Altered cholesterol metabolism is implicated in brain ageing and Alzheimer’s disease. We examined whether key genes regulating cholesterol metabolism and levels of brain cholesterol are altered in dementia and Alzheimer’s disease neuropathological change (ADNC). Temporal cortex (n = 99) was…

  17. Journal Article Full text

    Identification of Amino Acid Residues in CD81 Critical for Interaction with Hepatitis C Virus Envelope Glycoprotein E2

    Higginbottom, Adrian; Quinn, Elizabeth R.; Kuo, Chiung-Chi et al.

    J Virol · 2000 · English · PubMed Central

    Human CD81 has been previously identified as the putative receptor for the hepatitis C virus envelope glycoprotein E2. The large extracellular loop (LEL) of human CD81 differs in four amino acid residues from that of the African green monkey (AGM), which does not bind E2. We mutated each of the…

  18. Journal Article Full text

    C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis

    Cooper-Knock, Johnathan; Bury, Joanna J.; Heath, Paul R et al.

    PLoS One · 2015 · English · PubMed Central

    OBJECTIVE: An intronic GGGGCC-repeat expansion of C9ORF72 is the most common genetic variant of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. The mechanism of neurodegeneration is unknown, but a direct effect on RNA processing mediated by RNA foci transcribed from the repeat…

  19. Journal Article Full text

    Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy

    Cooper-Knock, Johnathan; Higginbottom, Adrian; Stopford, Matthew J. et al.

    Acta Neuropathol · 2015 · English · PubMed Central

    GGGGCC repeat expansions of C9ORF72 represent the most common genetic variant of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. We and others have proposed that RNA transcribed from the repeat sequence is toxic via sequestration of RNA-binding factors. Both GGGGCC-repeat (sense)…

  20. Journal Article Full text

    A bacterial artificial chromosome mouse model of amyotrophic lateral sclerosis manifests ‘space cadet syndrome’ on two FVB backgrounds

    Badger, Sophie E.; Coldicott, Ian; Kyrgiou-Balli, Ergita et al.

    Dis Model Mech · 2025 · English · PubMed Central

    C9orf72-related amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD) has proven difficult to model in mice. Liu et al. (2016) reported a bacterial artificial chromosome (BAC) transgenic mouse displaying behavioural, motor and pathological abnormalities. This was followed by multiple…